¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"POTASSIUM ACID PHOSPHATE"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
Asx amino acid that gives aspartic acid after hydrolysis; asymptomatic
ATS Achard-Thiers syndrome; acid test solution; alpha-D-tocopherol acid succinate; American Thoracic Soc...
BA Bachelor of Arts; backache; bacterial agglutination; basilar artery; basion; benzyladenine; best amp...
BAO-MAO basal acid output to maximal acid output [ratio]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
E4P D-erythrose 4-phosphate
F6P Fructose-6-phosphate
Glc6P D-glucose 6-phosphate
G3P D-glyceraldehyde 3-phosphate
GAP D-glyceraldehyde 3-phosphate
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • pyrophosphoric acid
    ÇÇ·ÎÀλê
  • pyruvic acid
    ÇÇ·çºê»ê
  • periodic acid-Schiff stain
    PAS¿°»ö
  • palmitic acid
    ÆÈ¹ÌÆ®»ê
  • retinoic acid
    ·¹Æ¼³ë»ê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê, RNA
  • saccharic acid
    »çÄ«¸°»ê
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • sorbic acid
    ¼Ò¸£ºê»ê
  • spermanucleic acid
    Á¤ÀÚÇÙ»ê
  • stearic acid
    ½ºÅ׾Ƹ£»ê
  • succinic acid
    ¼÷½Å»ê
  • sugar acid
    ´ç»ê
  • sulfuric acid
    Ȳ»ê
  • sulfurous acid
    ¾ÆÈ²»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • uric acid stone
    ¿ä»êµ¹
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • fuming sulfuric acid
    ¹ß¿¬È²»ê(¡­üÜß«).
  • gastric acid
    À§»ê(ß«)
  • gastric acid secretion
    À§(êÖ)(¾×(äû))»êºÐºñ(ß«ÝÂÝô).
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • general acid
    ÀϹݻê(ìéÚõß«).
  • glacial acetic acid
    ºùÃÊ»ê.
  • glucosidase, alpha-glucosidase(acid maltase)
    -±Û·çÄڽõ¥À̽º, -glucosidase
  • glucuronic acid
    ±Û·çÄí·Ð»ê.
  • glucuronic acid pathway
    ±Û·çÄí·Ð»ê°æ·Î.
  • glutamic acid
    ±Û·çŽ»ê.
  • glutamic acid dehydrogenase
    ±Û·çŽ»êÅ»¼ö¼ÒÈ¿¼Ò, ±Û·çŽ»êµ¥È÷µå·Î°Ô<³ª>Á¦.
  • glutaric acid
    ±Û·çŸ¸£»ê.
  • glyceric acid
    ±Û¸®¼¼¸°»ê(¡­ß«).
  • glyceroboric acid
    ±Û¸®¼¼¸£ºØ»ê
  • glycocholic acid
    ±Û¸®ÄÚÄÝ»ê.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • bacterium, lactic acid
    À¯»ê¼¼±Õ
  • basal acid output
    ±âÀú»ê¹èÃâ·®
  • benzoic acid
    º¥Á¶»ê
  • benzoic acid
    º¥Á¶»ê.
  • bile acid
    ´ãÁó»ê(ÓÅñðß«)
  • boric acid
    ¾à¸®ºØ»ê(ÝÝß«).
  • boric acid
    ºØ»ê(ºØ»ê).
  • boric acid
    ºØ»ê
  • boric acid ointment
    ºØ»ê¿¬°í(¡­æãÍÇ).
  • boric acid solution
    ºØ»ê¼ö(ÝÝß«â©).
  • branched chain amino acid
    ºÐÁö¼â¾Æ¹Ì³ë»ê
  • butyric acid
    ºÎƼ¸£»ê.
  • cacodylic acid
    Ä«ÄÚµô»ê.
  • caffeic acid
    Ä«ÆäÀλê
  • carbolic acid =phenol
    Ä«¸£º¼»ê(¡­ß«).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • folic acid coenzyme
    Æú»ê(ß«) º¸È¿¼Ò(ÜÍý£áÈ)
  • folic acid conjugate
    Æú»ê(ß«) Æ÷ÇÕü(øÙùêô÷)
  • folic acid reductase
    Æú»ê(ß«) ¸®´ÚÅ×À̽º
  • folinic acid
    Æú¸°»ê(ß«)
  • N5-formyltetrahydrofolic acid
    N5-Æ÷¸£¸» »ç¼ö¼Ò(ÞÌâ©áÈ)Æú»ê(ß«)
  • fulvic acid
    Ç®ºê»ê(ß«)
  • fumaric acid
    Ç»¸¶¸£»ê(ß«)
  • gamma aminobutyric acid
    °·¸¶ ¾Æ¹Ì³ëºêƼ¸£»ê(ß«)
  • general acid-base catalysis
    ÀϹÝ(ìéÚõ) »ê-¿°±â Ã˸Å(ß«-ç¤ÐñõºØÚ)ÀÛ¿ë
  • gibberellic acid
    Áö¹ö·¼¸°»ê(ß«)
  • glucoplastic amino acid
    ±Û·çÄÚ½º»ý¼º(ßæà÷) ¾Æ¹Ì³ë»ê(ß«)
  • glucuronic acid
    ±Û·çÅ¥·Ð»ê(ß«)
  • glucuronic acid oxidation pathway
    ±Û·çÅ¥·Ð»ê(ß«) »êÈ­°æ·Î(ß«ûùÌèÖØ)
  • glutamic acid
    ±Û·çŽ»ê(ß«)
  • glutaric acid
    ±Û·çŸ¸£»ê(ß«)
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • performic acid
    °úÀÇ»ê
    cysteinÀ» »êÈ­ÇÏ¿© cysteic acid·Î ÇÏ¿© ÆéŸÀ̵åÀÇ disulfide °áÇÕÀ» Âɰ³±â À§ÇÏ¿© »ç¿ëµÇ´Â À¯±â°ú»ê¼Ò»ê.
  • permanganic acid
    °ú¸Á°£»ê
    ÀÏ ¿°±â»ê. Áö¼ÓÀûÀÎ ½ÉÈ«»öÀ» °®´Â´Ù.
  • phosphoric acid
    Àλê
    ¿À»êÈ­ÀÎ PO°¡ ¼öÈ­ÇÏ¿© »ý±â´Â ÀÏ·ÃÀÇ »ê mPO, nHOÀÇ ÃÑĪ. ¸ÞŸ Àλê, ÇÇ·Î Àλê, ¿À¸£Åä Àλê, »ïÀλê, »çÀÎ»ê µîÀÌ ÀÖ°í, ÀÌ ¹Û¿¡ ¸ÞŸ ÀλêÀÇ ÁßÇÕ¿¡ ÀÇÇØ¼­ »ý±â´Â Æú¸® ¸ÞŸ ÀλêÀÇ °è¿­µµ ÀÖÀ¸³ª, ÀϹÝÀûÀ¸·Î´Â ¿À¸£Åä ÀλêÀ» °¡¸®Å²´Ù. ÀλêÀÇ ¼ºÁúÀº ¹«»ö, ¹«ÃëÀÇ Á¡¼ºµµ°¡ Å« ¾×üÀ̸ç, ³óµµ°¡ ³ô¾ÆÁö¸é °áÁ¤È­Çϱ⠽±´Ù. ³ì´ÂÁ¡ 42.35 ¡É, ºñÁß 1.834ÀÌ´Ù. Á¶ÇؼºÀÌ ÀÖ°í, 100 gÀÇ ¹°¿¡ 20 ¡É¿¡¼­ 542 g ³ì´Â´Ù. ºñÈֹ߼ºÀÌ¸ç °¡¿­Çϸé ÇÇ·Î ÀλêÀ̳ª Æú¸® ÀλêÀÌ µÇ°í, ´õ °¡¿­ÇÏ¸é ¸ÞŸ ÀλêÀÌ µÈ´Ù. ¾ËÄڿÿ¡µµ ³ì´Â´Ù. ±Ý¼Ó ¹× ±× »êÈ­¹°À» °Ý·ÄÇÏ°Ô Ä§½ÄÇÑ´Ù. ÀϹÝÀûÀ¸·Î »ýü ³»¿¡¼­´Â Àλê ÇüÅ·Î, »ý¹°°è¿¡¼­´Â Àλ꿰 ¶Ç´Â ÀÎ»ê ¿¡½ºÅ׸£ÀÇ ÇüÅ·ΠÇÙ»ê, ÀÎ ´Ü¹éÁú, ÀÎ ÁöÁú µî »ýüÀÇ ÁÖ¿ä ±¸¼º ¼ººÐÀ» Çü¼ºÇÑ´Ù. °í¿¡³ÊÁö ÀÎ»ê °áÇÕÀ» ¸¸µé¾î ¿¡³ÊÁö ¿î¹ÝüÀÇ ±¸½ÇÀ» ÇÏ´Â µî, »ýÈ­Çлó Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù.
  • polyacrylic acid
    Æú¸® ¾ÆÅ©¸±¸¯ »ê
  • polyenic acid
    Æú¸®¿£»ê
    ź¼ÒüÀÇ ÀÌÁß °áÇÕÀÌ µÎ°³ ÀÌ»ó Á¸ÀçÇÏ´Â Áö¹æ»ê.
  • polyunsaturate fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê
  • pyrophosphoric acid
    ÇÇ·ÎÀλê
    ¿À¸£Åä ÀλêÀ» 200-300µµ·Î ¿À·¡ °¡¿­ÇÒ ¶§ »ý±â´Â Å« °áÁ¤.
  • pyruvic acid
    ÆÄÀÌ·çºó»ê, Ãʼº Æ÷µµ»ê
    ź¼öÈ­¹° ´ë»çÀÇ Áß°£ ¹°Áú. ¶ó½Ã¹Ì »êÀ̳ª ÁÖ¼®»êÀÇ °Ç·ù¿¡ ÀÇÇØ »ý¼ºµÉ ¼ö ÀÖ´Ù.
  • quinaldinic acid
    Ű³¯µò»ê
  • quinolinic acid
    Ű³î¸°»ê
    ¹«»öÀÇ ÁÖ»ó °áÁ¾À¸·Î, Ű³î¸°ÀÇ »êÈ­ »ý¼º¹°.
  • ribonucleic acid
    ¸®º¸ ÇÙ»ê
    È¿¸ð¿¡¼­ óÀ½À¸·Î ºÐ¸®µÈ ÇÙ»êÀ¸·Î ³ªÁß¿¡´Â ¸ðµç »ì¾ÆÀÖ´Â ¼¼Æ÷¿¡¼­µµ ¹ß°ßµÇ¾ú´Ù. °¡¼öºÐÇØÇÏ¸é ¾Æµ¥´Ñ, ±¸¾Æ´Ñ, »çÀÌÅä½Å, ¿ì¶ó½Ç, ¶ûº¸½º, ÀλêÀÌ »ý±ä´Ù. RNA¶ó ¾à±âÇÑ´Ù.
  • saccharic acid
    »çÄ«¸°»ê, ´ç»ê, »èÄ«¸°»ê
    1. ÀÌ¿°±â»ê. COOH,
  • salicylic acid test
    »ì¸®½Ç»ê ½ÃÇè
  • saturated fatty acid
    Æ÷È­ Áö¹æ»ê
  • serum bile acid
    Ç÷û ´ãÁó»ê
    ¹Ì·® Á¸ÀçÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
polyisoprenyl phosphate sugars Compounds functioning as activated glycosyl carriers in the biosynthesis of glycoproteins and glycophospholipids. They include the polyisoprenyl pyrophosphates.
(12 Dec 1998)
polyphloretin phosphate <chemical> A polymeric mixture of polyesters of phosphoric acid and phloretin. It blocks some cellular responses to prostaglandins.
Pharmacological action: prostaglandin antagonists.
Chemical name: 1-Propanone, 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-, phosphate, homopolymer
(12 Dec 1998)
myo-inositol-1-phosphate dehydrogenase <enzyme> Requires nad+, forms ribulose 5-phosphate
Registry number: EC 1.1.1.-
Synonym: inositol-1-phosphate dehydrogenase
(26 Jun 1999)
myo-inositol-1-phosphate synthase <enzyme> An enzyme that catalyses the formation of myo-inositol-1-phosphate from glucose-6-phosphate in the presence of NAD.
Chemical name: 1L-myo-Inositol-1-phosphate lyase (isomerizing)
Registry number: EC 5.5.1.4
(12 Dec 1998)
creatine phosphate <biochemistry> Storage compound of vertebrate muscle.
See: creatine kinase.
(18 Nov 1997)
cyclic inositol phosphate 1, 2 cyclic derivatives of inositol phosphatide that are invariably formed during enzymic hydrolysis of phosphatidyl inositol species. Have been proposed as second messengers in hormone activated pathways.
(18 Nov 1997)
cyclic phosphate An activator of phosphorylase kinase and an effector of other enzymes, formed in muscle from ATP by adenylate cyclase and broken down to 5'-AMP by a phosphodiesterase; sometimes referred to as the "second messenger." A related compound (2',3') is also known.
Synonym: cyclic adenylic acid, cyclic AMP, cyclic phosphate.
Acronym: cAMP
(05 Mar 2000)
prednisolone sodium phosphate Prednisolone 21-(disodium phosphate);more soluble than prednisolone and the other prednisolone esters and useful when a rapid onset or a short duration of action is desired; suitable for intrasynovial, parenteral, and topical administration.
Prednisolone succinate, prednisolone compound suitable for intramuscular, intravenous, or rectal administration.
Prednisolone tebutate, same actions and uses as prednisolone but with longer duration of action and suitable for intrasynovial and soft tissue injection.
Synonym: prednisolone butylacetate.
(05 Mar 2000)
cytidine phosphate See: cytidylic acid.
(05 Mar 2000)
primaquine phosphate 8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline phosphate (1:2);an antimalarial agent especially effective against Plasmodium vivax, terminating relapsing vivax malaria; usually administered with chloroquine.
Primaquine phosphate sensitivity, a sensitivity to primaquine phosphate observed in individuals with glucose-6-phosphate dehydrogenase deficiency.
(05 Mar 2000)
S-adenosylmethionine-dependent phosphate methyltransferase <enzyme> A membrane-bound, phosphorylated oligosaccharide-specific enzyme that selectively methylates the phosphate group of mannose-6-phosphate
Registry number: EC 2.1.1.-
Synonym: adomet-dependent phosphate methyltransferase, adomet-po4 methyltransferase, mannose-6-phosphate methyltransferase
(26 Jun 1999)
primary sodium phosphate NaH2PO4-H2O;used to increase urinary acidity.
Synonym: primary sodium phosphate, sodium acid phosphate, sodium dihydrogen phosphate.
(05 Mar 2000)
hexose-1-phosphate uridylyltransferase <enzyme> An enzyme that catalyses the transfer of ump from udpglucose to galactose 1-phosphate, forming udpgalactose and glucose 1-phosphate. Deficiency in this enzyme is the major cause of galactosaemia.
Chemical name: UDPglucose:alpha-D-galactose-1-phosphate uridylyltransferase
Registry number: EC 2.7.7.12
(12 Dec 1998)
hexose phosphate synthetase <enzyme> Ribulosephosphate formaldehyde gives d-erythro-l-glycero-3-hexulose
Registry number: EC 4.1.2.-
Synonym: 3-hexulose phosphate synthase, d-arabino-3-hexulose 6-phosphate formaldehyde-lyase, 3-hexulosephosphate synthase, d-arabino-3-hexulose-6-phosphate-lysase, hexulose-6-phosphate synthase, hump synthase
(26 Jun 1999)
high energy phosphate bond See: high energy phosphates.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á